Startseite>>Signaling Pathways>> Cell Cycle/Checkpoint>> Inositol Phosphates>>D-myo-Inositol-1,2-diphosphate (sodium salt)

D-myo-Inositol-1,2-diphosphate (sodium salt) (Synonyms: Ins(1,2)P2 (sodium salt), 1,2IP2 (sodium salt))

Katalog-Nr.GC43513

Ins(1,2)P2 (sodium salt) is one of the many inositol phosphate (InsP) isomers that could act as small, soluble second messengers in the transmission of cellular signals.

Products are for research use only. Not for human use. We do not sell to patients.

D-myo-Inositol-1,2-diphosphate (sodium salt) Chemische Struktur

Cas No.: 208584-51-4

Größe Preis Lagerbestand Menge
100μg
83,00 $
Auf Lager
500μg
378,00 $
Auf Lager
1mg
672,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Ins(1,2)P2 (sodium salt) is one of the many inositol phosphate (InsP) isomers that could act as small, soluble second messengers in the transmission of cellular signals. The most studied InsP Ins(1,4,5)P3, is a second messenger produced in cells by phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositol-4,5-biphosphate. Binding of Ins(1,4,5)P3 to its receptor on the endoplasmic reticulum results in opening of the calcium channels and an increase in intracellular calcium. Ins(1,2)P2 (tested as the D/L racemic mixture) is ~1,000-fold less potent than Ins(1,4,5)P3 at initiating Ca2+ release when injected into Xenopus oocytes.

Bewertungen

Review for D-myo-Inositol-1,2-diphosphate (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-myo-Inositol-1,2-diphosphate (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.